Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

All over-50s to get a new Covid jab targeted to protect against Omicron variant

Britain became the first country to approve a “bivalent” jab on Monday that directly targets Omicron and the original Covid-19 strain - as 29 million people will initially be invited for the vaccine

Daily Mirror

‘No second-rate vaccines’ health chief insists as half will miss out on dual-strain booster

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available

The Independent UK

Who can get Covid booster as new Omicron jab that targets Omicron to be used

The new jab is bivalent, meaning it protects against the original Covid strain as well as the Omicron variant

Daily Record

From analysis to the latest developments in health,
read the most diverse news in one place.

The U.K. approved omicron-specific booster shots. They're coming to the U.S. soon

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

WEKU

Full details of next Covid booster rollout -and Omicron jab will be used

The Government has confirmed who will get another Covid injection and says new vaccine will be used

Wales Online

The UK Approved A Combo Vaccine To Protect Against Omicron Variants Pls Givvus That One Next

Moderna's bivalent vaccine is seen as the "next step" in COVID protection.

Pedestrian.tv

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Labor doubles down on domestic manufacturing

The prime minister has made claims Australia must be more self-reliant.

The Canberra Times

Australian virus cases close to 10 million

The total number of COVID-19 cases identified in Australia since the start of the pandemic is closing in on 10 million.

AAP

Moderna vaccine: how the new Covid bivalent Omicron jab works

An Omicron-specific booster vaccination has been approved in the UK

Evening Standard

Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart

Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.

Benzinga

First Covid-19 jab to target two strains included in autumn booster programme

Adults over 50 and clinically vulnerable people will be offered the first Covid-19 jab to target two strains of the virus, as part of the UK’s autumn booster programme.

Evening Standard

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

The Independent UK

Who can get a Covid vaccine booster in the UK?

The autumn booster program for Covid vaccinations will begin shortly. Over 50s, carers, frontline health workers and those at clinical risk will be inited to get a booster jab.

Edinburgh Live

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Independent UK

Covid: New dual-strain booster vaccine targeting Omicron to be rolled out in autumn

UK first country to approve use of so-called bivalent vaccine as officials prepare for winter and expected rise in Covid cases

The Guardian - UK

Dual-variant Covid vaccine approved for UK booster programme

Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator

Tribune News Service

UK takes world’s first step toward omicron-tailored shot

The U.K. has granted the world’s first approval for a COVID-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus.

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Record

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

The Independent UK

British regulator 1st to OK Moderna's updated COVID booster

British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant

Manchester Evening News

New Moderna vaccine to target two Covid strains in one dose

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

The Times of India

Coronavirus: UK approves Moderna vaccine targeting Omicron variant, key points to know

The UK's Medicine and Healthcare products Regulatory Agency (MHRA) has approved an updated Moderna vaccine against the coronavirus' Omicron variant.

The National (Scotland)

'Next generation' Covid jab approved in UK for use in adults

A new coronavirus booster jab has been approved for use in adults.

The Independent UK

New Omicron-specific vaccine from Moderna approved by UK regulator

New vaccine is a ‘sharpened tool in our armoury’ to fight against Covid, says Dr June Raine, chief for the UK medicines regulator

Daily Mirror

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

US Food and Drug Administration

63 stories

Nature Medicine

35 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.